GastroAGI Logo
OverviewBlogsAbout
Trending TopicsDaily BriefConference

Trending Topics in Gastroenterology

Explore current gastroenterology questions, clinical answers, and emerging research by topic.

01

High-Risk ACLF: Should Antifungal Therapy Start Before Infection Is Proven?: AJG | September 2026

What Did the Study Find? This pragmatic RCT randomized 216 hospitalized patients with ACLF and predefined risk factors for invasive fungal infection (IFI) to immediate empirical antifungal therapy...

02

Statins After MASLD-Cirrhosis Decompensation: Digestive Diseases and Sciences

Introduction: Statins have been associated with potential hepatic benefits in compensated cirrhosis, but whether they improve outcomes after MASLD cirrhosis has already decompensated remains uncertain. This study examined...

03

ELM Score Could Shrink the “Grey Zone” in Non-Invasive CSPH Diagnosis: Journal of Hepatology | September 2026 Study

Introduction: Baveno criteria have transformed non-invasive diagnosis of clinically significant portal hypertension (CSPH), but many patients remain in an indeterminate “gray zone.” The ELASTO-ML study developed a machine-learning...

04

Prior Ascites or Encephalopathy Signals High Risk After Variceal Bleeding: CGH | August 2026

Introduction: After variceal haemorrhage, secondary prophylaxis with nonselective beta-blockers (NSBBs) plus endoscopic variceal ligation (EVL) is standard. However, prognosis may differ substantially according to the patient’s previous pattern...

05

PEth Improves Classification of MASLD, MetALD and Alcohol-Associated Liver Disease: Lancet Gastroenterology & Hepatology | September 2026

Introduction: Distinguishing MASLD, MetALD and alcohol-associated liver disease (ALD) depends heavily on self-reported alcohol intake, which is vulnerable to underreporting. This prospective study evaluated phosphatidylethanol (PEth) as an...

06

RPR Predicts Short-Term Acute Decompensation in Alcohol-Related Cirrhosis: Digestive and Liver Disease | 2026

Introduction: Patients with alcohol-related cirrhosis and non-acute decompensation (NAD) may appear sufficiently stable for outpatient management but remain at substantial risk of rapidly progressing to hospitalisation-requiring acute decompensation...

07

ACLF Needs One Language: Journal of Hepatology | August 2026

Introduction: Acute-on-chronic liver failure (ACLF) is a high-mortality syndrome characterised by acute deterioration of chronic liver disease with organ dysfunction or failure. Yet, unlike conditions such as sepsis...

08

Breath-Based Sensor (LivSens) Shows Promise for Screening HE: JHE | August 2026

Hepatic encephalopathy (HE) is usually diagnosed through clinical assessment and psychometric testing, but these approaches can be time-consuming and require trained personnel. LivSens is a portable multisensor breath-analysis...

09

Breath-Based Diagnostics: Measuring the Liver’s Functional Reserve in Real Time: CGH | August 2026

Introduction: Current assessment of chronic liver disease relies largely on static biomarkers and structural measurements such as laboratory scores, elastography, imaging, and liver biopsy. However, fibrosis severity does...

10

Hyponatremia in Cirrhosis: Low Sodium Reflects Excess Water, Not Sodium Deficiency: AASLD Clinical Pearls | August 2026

Introduction: Hyponatremia is common in advanced cirrhosis, particularly in patients with ascites, and reflects impaired free-water excretion due to effective arterial underfilling rather than true sodium depletion in...

Previous
1212
Next
GastroAGI Logo

We are pioneers in clinical intelligence, dedicated to helping gastroenterologists harness the power of artificial intelligence to drive precision, efficiency, and patient growth.

For You

For StudentsFor CliniciansFor ResearchersFor Patients

Core Tools

MELD-Na ScoreChild-PughFIB-4 IndexGlasgow-BlatchfordBISAP Score

Explore

OverviewAboutCalculators
Trending Topics
Conference Briefings
Blog Insights
©GastroAGI 2026
Privacy PolicyTerms of UseMedical Disclaimer